null

Anifrolumab Biosimilar (Anti-IFNAR1) Antibody (HDBS0102)

SKU:
HDBS0102
Antibody Type:
Biosimilar Reference Antibody
Applications:
Drug Development
Inflammatory Response Assays
Pharmacokinetics
Disease Area:
Viral Infections
Disease Area:
Autoimmune Diseases
Protein:
IFNAR1
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399

Description

system_update_altDatasheet

Anifrolumab (Anti-IFNAR1) Biosimilar Antibody (HDBS0102)

The Anifrolumab Biosimilar Anti-IFNAR1 Antibody is a cutting-edge product designed for research in immunology and autoimmune disorders. This monoclonal antibody targets the interferon alpha/beta receptor subunit 1 (IFNAR1), a key player in immune signaling pathways. By specifically binding to IFNAR1, this antibody allows for the detection and analysis of IFNAR1 levels in various cell types, providing valuable insights into immune response modulation. Its high specificity and sensitivity make it an essential tool for studies on diseases like lupus, multiple sclerosis, and other autoimmune conditions where IFNAR1 signaling is dysregulated.

Whether used in Western blot applications or other experimental techniques, the Anifrolumab Biosimilar Anti-IFNAR1 Antibody offers researchers a reliable and versatile solution for investigating the role of IFNAR1 in immune regulation and autoimmune diseases. Stay ahead in your research with this innovative antibody.